Angiotensin-Neprilysin Inhibition and Renal Outcomes in Heart Failure with Preserved Ejection Fraction. Mc Causland FR, Lefkowitz MP, Claggett B, Anavekar NS, et al. Circulation 2020 Aug 17. doi: 10.1161/CIRCULATIONAHA.120.047643.

Read + Share

Amedeo Smart

Independent Medical Education

Mc Causland FR, Lefkowitz MP, Claggett B, Anavekar NS, et al. Angiotensin-Neprilysin Inhibition and Renal Outcomes in Heart Failure with Preserved Ejection Fraction. Circulation 2020 Aug 17. doi: 10.1161/CIRCULATIONAHA.120.047643.
PMID: 32845715